The government has established a committee to create rules for prosecuting chemists and retailers selling spurious drugs. This initiative a...

Nutraceuticals are products derived from food sources that are believed to provide extra health benefits besides the basic nutritional valu...

The development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceutica...

"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...

Experts are of the view that the clinicians can use it in their wisdom, but decided against recommending the drug in the national guideline...

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization deliberated upon Hyderabad-based Bharat Biotech...

The Drug Controller General of India (DCGI) will give the final approval to both the vaccine candidates.

Somani’s statement on Thursday comes on the day Prime Minister Narendra Modi said India is making preparations for the largest adult immuni...

In a meeting held on Monday, Subject Expert Committee (SEC) on COVID-19 at the CDSCO, deliberated on the application and asked the firm to ...

The committee, set up by the cabinet secretary after Prime Minister Narendra Modi sought overhauling of the country’s drug regulatory syste...

A high-level committee has proposed three options — Central Medical Products Administration, India (CMPA), Central Medical Products Regulat...

A committee led by cabinet secretary Rajiv Gauba has also decided to set up a nodal coordination committee to ensure expeditious disposal o...

Faced with the ominous threat of the coronavirus infection, a number of steps such as fast-tracking the approval process for drugs, researc...

If the affected patients approach the state-level committee, they may write to the concerned state drug controller who will be the member s...

Drug regulator accused of "criminal negligence" for taking 3 years to issue a medical device alert about the faulty implants.

All patients who got the implants will be evaluated individually to gauge the extent of medical problems arising from the bad implants and ...

The panel took note of specific cases, where approvals were granted for additional use for existing drugs without mandatory clinical trials.